Armotraz 1mg Anastrozole Tablet

Q1: What is Armotraz (Anastrozole) used for?

Armotraz is a generic anastrozole tablet used to treat hormone receptor-positive (HR+) breast cancer in postmenopausal women — as initial adjuvant therapy after surgery, as extended adjuvant therapy following tamoxifen, and for advanced/metastatic disease.

Q2: How does Armotraz work against breast cancer?

Armotraz is a potent non-steroidal aromatase inhibitor that blocks the aromatase enzyme complex, preventing conversion of androgens to estrogens. This achieves >80% suppression of plasma estradiol, depriving HR+ tumor cells of their growth stimulus.

Q3: What type of breast cancer is Armotraz indicated for?

Armotraz is indicated specifically for hormone receptor-positive (ER+/PR+) breast cancer in postmenopausal women. It is not effective for hormone receptor-negative breast cancers.

Q4: How is Armotraz administered?

One 1mg tablet is taken orally once daily, with or without food, at a consistent daily time. Treatment is continuous with no scheduled breaks unless directed by your oncologist.

Q5: How long does Armotraz treatment last?

Standard adjuvant treatment duration is 5 years. In extended adjuvant settings (following tamoxifen), treatment may continue for an additional 5 years. Duration is individualised by your oncologist.

Q6: What are the most common side effects of Armotraz?

Common side effects include hot flashes, weakness (asthenia), joint and muscle pain, throat irritation, and mild depression or mood changes. These are generally related to estrogen depletion.

Q7: What serious side effects require emergency care?

Contact your oncologist urgently for bone fractures, signs of heart attack or stroke, severe allergic reactions (hives, swelling, breathing difficulty), or symptoms of liver problems (jaundice, severe abdominal pain).

Q8: What drugs interact with Armotraz?

Estrogen-containing products (HRT, contraceptive pills) neutralise Armotraz's mechanism and are contraindicated. Tamoxifen should not be combined with Armotraz. Warfarin users require close INR monitoring.

Q9: Is Armotraz safe during pregnancy?

No. Armotraz is contraindicated in pregnancy and is only indicated for postmenopausal women. Pre-menopausal women must not use it without confirmed ovarian suppression and effective contraception.

Q10: What monitoring is required during Armotraz treatment?

Bone mineral density (DXA scan) at baseline and every 1–2 years during treatment, cardiovascular risk factor monitoring, and periodic liver function assessment are recommended.

Q11: How should Armotraz be stored?

Store at room temperature 20°C–25°C in the original packaging, away from moisture and direct sunlight. Keep out of children's reach and do not use after the expiry date.

Q12: Is Armotraz available without a prescription?

No. Armotraz is a prescription-only oncology medication. It must be prescribed by an oncologist and taken as part of a supervised breast cancer treatment plan.